Cencora (COR)
NYSE: COR · IEX Real-Time Price · USD
229.45
-9.61 (-4.02%)
May 1, 2024, 12:55 PM EDT - Market open

Cencora Revenue

Cencora had revenue of $271.58B in the twelve months ending December 31, 2023, with 12.31% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $72.25B with 14.97% year-over-year growth. In the fiscal year ending September 30, 2023, Cencora had annual revenue of $262.17B with 9.89% growth.

Revenue (ttm)
$271.58B
Revenue Growth
+12.31%
P/S Ratio
0.17
Revenue / Employee
$5,903,900
Employees
46,000
Market Cap
45.88B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023262.17B23.59B9.89%
Sep 30, 2022238.59B24.60B11.50%
Sep 30, 2021213.99B24.09B12.69%
Sep 30, 2020189.89B10.30B5.74%
Sep 30, 2019179.59B11.65B6.94%
Sep 30, 2018167.94B14.80B9.66%
Sep 30, 2017153.14B6.29B4.29%
Sep 30, 2016146.85B10.89B8.01%
Sep 30, 2015135.96B16.39B13.71%
Sep 30, 2014119.57B31.61B35.94%
Sep 30, 201387.96B9.88B12.65%
Sep 30, 201278.08B-614.85M-0.78%
Sep 30, 201178.70B919.20M1.18%
Sep 30, 201077.78B6.02B8.38%
Sep 30, 200971.76B1.57B2.24%
Sep 30, 200870.19B4.52B6.88%
Sep 30, 200765.67B4.86B7.99%
Sep 30, 200660.81B6.24B11.42%
Sep 30, 200554.58B1.46B2.74%
Sep 30, 200453.12B3.54B7.13%
Sep 30, 200349.58B4.35B9.61%
Sep 30, 200245.23B29.04B179.38%
Sep 30, 200116.19B4.55B39.04%
Sep 30, 200011.65B1.84B18.74%
Sep 30, 19999.81B304.33M3.20%
Sep 30, 19989.50B1.20B14.51%
Sep 30, 19978.30B2.64B46.55%
Sep 30, 19965.66B993.77M21.28%
Sep 30, 19954.67B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
McKesson 301.51B
Takeda Pharmaceutical 29.40B
Becton, Dickinson and Company 19.49B
IQVIA Holdings 14.98B
Zoetis 8.54B
Moderna 6.85B
Agilent Technologies 6.74B
Edwards Lifesciences 6.00B
Revenue Rankings